Limits Of FDA’s Risk Management Practices Shown In Renewed Duragesic Warnings
This article was originally published in The Pink Sheet Daily
Executive Summary
Fentanyl patch will get stronger labeling and a patient MedGuide, but FDA opts against a more interventionist approach as it issues its second public health advisory in two years about the risk of death.